Biomedical Laboratory Science

ShareThis

Showing posts with label Combined Vaccines. Show all posts
Showing posts with label Combined Vaccines. Show all posts

Wednesday, April 13, 2016

Combined HIV-Hepatitis C Vaccine Soon Preventing Co-Infection

Some 2.3 million people around the world are infected with both HIV and the hepatitis C virus (HCV) at the same time. The two are often intertwined, with HCV being the top cause of death aside from AIDS for co-infected patients. While there are currently vaccines for both hepatitis A and hepatitis B, there is no vaccine for hepatitis C. Likewise, HIV/AIDS treatment has improved significantly in recent decades, but there is still no vaccine.

In a new study, researchers note that a combined HIV and hepatitis C vaccine may soon be on the horizon. The study, which was presented at The International Liver Congress in Barcelona, describes how a combined vaccine would involve two main steps: first, exposing the immune system to adenoviral vectors that contain fragments of both HCV and HIV viruses, which would trigger antigens; and afterwards, administering booster vaccinations in an MVA vector containing the same HCV and HIV virus fragments.

“Finding effective vaccinations against the world’s biggest killers is a huge and pressing problem,” said Laurent Castera, Secretary General of the European Association for the Study of the Liver, in a statement. “This study shows for the first time that it is possible to generate simultaneous immune response against diseases HCV and HIV, raising the possibility of a combined vaccination.”

HIV, or the human immunodeficiency virus, causes HIV infection and over time, acquired immunodeficiency syndrome (AIDS). HCV is also a viral infection that mostly targets the liver, resulting in symptoms of fever, dark urine, stomach pain, and eventually liver disease, cirrhosis (scarring of the liver), or liver failure.

Read more: Combined HIV-Hepatitis C Vaccine Soon Preventing Co-Infection


Related Posts Plugin for WordPress, Blogger...

AddToAny